We organize your labs, genome, imaging, wearables and medical history into one clinician-informed map of risks, priorities and next steps — with AI-assisted synthesis and human clinical judgment, with physician review where applicable.
Most healthcare still reads snapshots. Veraxon reads trajectory.
The Veraxon Healthspan Index is not a diagnosis. It is a structured way to organize multi-domain signals and track direction over time.
Your labs sit in one portal. Genetics in another. Wearables in an app. Imaging in PDFs. Supplements in notes. Each visit starts from zero. No one sees the full trajectory — least of all you.
Six portals, three apps, a folder of PDFs. No single view of where your biology is heading.
A single value in a single visit hides the direction and rate of change that actually matter.
Measurable change often begins years before a diagnosis — but only if someone is reading the records.
Three values, each "within range" on its own day — yet the trajectory tells a different story. Veraxon reads the line, not the dots.
Veraxon organizes your clinical, genomic, metabolic, wearable and historical signals into one continuous view — so every consultation starts with synthesis already done, not scattered PDFs.
A structured inventory of your labs, imaging, genome, wearables and medical history in one place.
Cardiometabolic, inflammatory, hormonal, oncologic and neurocognitive signals organized by priority.
What is known, what is outdated, what is missing — and what may be worth testing next.
A practical plan for next steps, prepared for review by appropriately licensed clinicians where applicable.
Labs, wearables and interventions tracked over time — never interpreted as isolated snapshots.
Each signal tells part of the story. Veraxon connects them into one clinical narrative.
How fast your biology is changing right now.
Heart, liver, immune and other system-level signals.
Clinical biomarkers and methylation patterns read together.
The value is not the number — it's direction, rate and response.
Aging is not a single clock. It is an orchestra — and measuring it with one instrument is a way to deceive yourself, ten years into the future.
A short, non-sensitive inquiry. No medical records at this stage.
Documents shared only through a consent-based, secure workflow.
Your records are structured into a single Health Data Map.
Signals analyzed against current literature and your own trajectory — prepared for review.
Reviewed by appropriate licensed clinicians where applicable. Humans decide.
A roadmap you can act on — then tracked over time, not left as a one-time report.
The founding case behind the Veraxon methodology — built first on a physician's own 13-year dataset.
Not a testimonial. Not a guarantee. A demonstration of why the system is built the way it is.
Patient X is the founding physician of Veraxon. Individual results vary and are not guaranteed. All metrics are from real longitudinal records, anonymized where appropriate.
Epigenetic pace-of-aging was tracked during the founding longitudinal case. This is a single-founder case study, not a promised outcome. DunedinPACE and related measures should be interpreted in clinical context, not as standalone diagnoses.
We do not treat genetic findings as destiny. Genomics informs risk, prioritization and monitoring — not panic.
We build decisions from evidence, trajectory and context — not hope.
No single institution holds a monopoly on biological insight. Veraxon draws on methods and technologies from across the world — while clinical responsibility stays local, with appropriately licensed clinicians where clinical review is part of the pathway.
Genomics, AI infrastructure and advanced analytics.
Privacy standards, clinical rigor, immunology and metabolic medicine.
Microbiome, rapid diagnostics and emerging health technologies.
One patient. Many signals. One clinical narrative.
Veraxon does not replace your physician. It organizes the data, builds the clinical intelligence layer, and helps route decisions to the right human expert.
Clear, clinical explanations of the signals that matter — written for decision-making, not for hype.
Three minutes. A preliminary sense of which pathway fits — before any sensitive data is shared.
This is a preliminary suggestion, not a medical recommendation. The next step is a short, non-sensitive inquiry.
Request a private data reviewFor people who already have labs, genetics or wearables and need structure and interpretation.
For people who want a comprehensive starting point across all data layers.
For people who want ongoing monitoring and clinician coordination over time.
Nothing is uploaded through this public page. Initial contact is limited to non-sensitive information.
AI supports synthesis, triage and organization. Medical decisions are made by licensed clinicians where applicable.
Veraxon routes each inquiry according to the client's location and applicable law.
Medical documents are handled only through secure, consent-based workflows.
This is a preliminary inquiry only — no medical records at this stage. If there is a fit, we follow up with a secure intake and a short call.
Initial data review may be available depending on client location, requested service, data type and applicable law.
US pathway is in preparation for 2026. Waitlist inquiries are open; clinical services will be available only through appropriately licensed clinicians and compliant entities.